"This bipartisan legislation will eliminate the pill penalty and help ensure science and researchers – not government bureaucrats – determine the possible treatments innovator companies pursue," said BIO CEO and president John Crowley. …
US biotech industry welcomes proposed change to price negotiation power
February 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
Noxopharm advances autoimmune candidate as first multiple-dose cohort clears safety review
December 3, 2025 - - Australian Biotech -
Cost of multiple sclerosis in Australia surges as prevalence accelerates
December 3, 2025 - - Latest News -
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 - - Latest News -
Reforming Australia’s Opioid Dependence Treatment Program - From red tape to person-centred care
December 2, 2025 - - Latest News -
Novo Nordisk raises over $106,000 for Type 1 Diabetes research
December 2, 2025 - - Latest News -
Seqirus opens world-class cell-based vaccine and antivenom manufacturing facility
December 2, 2025 - - Latest News -
CLINUVEL advances second therapy toward market with planned 2026 European filing
December 2, 2025 - - Australian Biotech